Mds Podcast

Dr. Mena Farag joins Dr. Eduardo de Pablo-Fernández to discuss how proenkephalin and other biomarkers can help monitor the earliest stages of Huntington's disease decades before the onset of motor symptoms. Read the article.

This episode explores shame as an often-overlooked but impactful non-motor symptom of Parkinson’s disease. Drawing on her team's recent research, Dr. Vanessa Fleury discusses the psychological and clinical determinants of shame, its strong link to quality of life, and why it deserves greater attention in routine care. The conversation highlights how recognizing and addressing shame may open new avenues for more holistic, patient-centered management. Read the article.

In this episode, Dr. Alexander Lehn explores the clinical management of Parkinson’s disease across the reproductive journey; before conception, during pregnancy, and in the postpartum period. He shares the current evidence, practical challenges, medication safety considerations, and multidisciplinary decision-making. The conversation highlights gaps in data, real-world clinical strategies, and key counseling points to support optimal outcomes for both the parent and child. Read the article.

Dr. Sara Schaefer is joined by Dr. Valentina Leta and Dr. Ray Chaudhuri to discuss their randomized controlled trial on the effects of probiotic use on inflammation, motor, and non-motor symptoms in Parkinson's disease. Journal CME is available until December 18, 2026 Read the article.

In another installment of the ongoing History Series, Dr. Christopher Goetz joins Dr. Sara Schaefer to discuss the legacy of Jean-Martin Charcot within the fields of medicine medicine, neurology, medical education, and movement disorders.

Dr. Sarah Camargos continues her conversation on palliative in movement disorders by interviewing Mr. Victor McConvey. Together they discuss the current state of palliative care in movement disorders including current barriers, challenges, and future goals.

Differentiating a dystonic head tremor from a head tremor in essential tremor can sometimes be diagnostically challenging. In this episode, Dr. Mitra Afshari interviews Dr. Jung Hwan Shin and Prof. Beomseok Jeon on their investigation into the rhythmicity and sinusoidality of head tremors in cervical dystonia versus essential tremor using simple 2D video recordings. We’ll hear about how their findings fit their original hypotheses and potential future work that the group has been brainstorming. Journal CME is available until November 26, 2026 Read the article.

To celebrate the 40th Anniversay of the MDS, Dr. Michele Matarazzo sits down with two key leaders of the MDS Asian Oceanian section, Prof. Carolyn Sue and Prof. Beomseok Jeon. Together they discuss the early years of movement disorder “rock stars”, how the society has changed through their eyes, and impacts it has had on their careers.

To celebrate the 40th Anniversary of the MDS, Dr. Michele Matarazzo sits down with two key leaders of the MDS Pan-American section, Dr. Cynthia Comella and Dr. Oscar Gershanik. Together they discuss how they got involved in the society, what they are most proud of, and what the Society means to them, both professionally and personally.

To celebrate the 40th Anniversay of the MDS, Dr. Sara Schaefer sits down with two key leaders of the MDS European Regional Section, Prof. Marie Vidailhet and Prof. Alberto Albanese. Listen as they share their fond memories of scholarly debate, Congress experiences, and hopes for the future.

To celebrate the 40th Anniversay of the MDS, Dr. Sara Schaefer sits down with two key leaders of the MDS African Regional section, Dr. Njideka Okubadejo and Dr. Jonathan Carr. Together they discuss their experiences within MDS and what makes them proud to be long-standing members.

In this Hot Topic episode, Dr. Sarah Camargos talks with Prof. Janis Miyasaki about the meaning and benefits of palliative care and how it improves quality of care in movement disorders.

In this episode, Prof. Fanny Mochel discusses the rationale and key findings from a retrospective cohort study of patients with CSF1R-related disorder treated with hematopoietic stem cell transplantation, highlighting the potential of this therapy to achieve both clinical and radiological disease stabilization. Journal CME is available until September 24, 2026 Read the article.

In this episode, Dr. Divyani Garg converses with Prof. Kristina Simonyan on applying the standard alcohol challenge test, in combination with targeted genetic analysis in the GABAergic synapse pathways, in persons with laryngeal dystonia. Together they explore alcohol’s role in laryngeal dystonia, the genetic signatures that may predict responsiveness, and what this could mean for the future of treatment of laryngeal dystonia specifically, but also dystonia in general. Read the article.

Dr. Sarah Camargos interviews Dr. Guillaume Cogan and Prof. Alexis Brice, the corresponding authors of the article selected as the Movement Disorders Review of the Year. Listen as their conversation dives into the new sequencing technologies, and the broader diagnosis they bring to the field.

Dr. Michele Matarazzo interviews Dr. Victor Hvingelby, the recipient of this year’s MDJ Research Article of the Year award. Together they discuss the use of PET tracers to assess microglial activation in isolated REM sleep behavior disorder and how these tools can better define prodromal Parkinson’s disease.

Developments in neuroimaging have grown a lot over the years. Dr. Thilo van Eimeren discusses biomarker development, both in tau and alpha synuclein, current research, and his hope for future successes.

Dr. Alessandra Fanciulli discusses how the MDS criteria for the diagnosis of MSA has made an impact on the field, the status of biomarker research, and optimal targets for disease-modifying trials for MSA.

Dr. Lauren Jackson discusses recent clinical trials, genetic updates, and interesting research in the field of ataxia.

Prof. Susanne Schneider discusses all things dystonia. Listen as she reviews the revised MDS definition and classification system for dystonia, updates for neurodegeneration with brain iron accumulation, and the exciting future of genetic therapies.